4 of 12
DOGNINI ET AL.
TABLE 2 Factorial design space - high and low settings for each
factor
in high-resolution NMR tubes with 0.7 mL of each sample. Signals
were observed as singlets for the products of interest, which were
assigned based on known 19F NMR resonance data.[15,16] Data
analysis (integration, peak-picking) was carried-out using TopSpin
3.1, Bruker UK Ltd (Coventry, UK). All spectra are provided in
Figures S5-S35).
Controllable factor
Time
Low setting
4 hours
5 mL
High setting
168 hours
10 mL
Solvent volume
Temperature
21 ꢀ
4
C
50 ꢀ
10
C
Mol. equation N-acetyl cysteine
Mol. eq. Cs2CO3
Solvent
8
20
2.3
|
Liquid chromatography-mass spectrometry
DMSO
(high resolution) analysis
Characterization of crude peptides and reaction products were con-
ducted using an Agilent 1260 Infinity II LC system with Agilent 6530
Accurate-Mass QToF spectrometer, equipped with an Agilent
ZORBAX SB-C18 Stable Bond Analytical (5 μm particle size,
4.6 × 150 mm) from Agilent Technologies UK Limited (Cheadle, UK)
with a binary eluent system comprising MeCN/H2O (25 minutes gra-
dient: 1%-99% with 0.1% formic acid) as mobile phases. MS grade sol-
vents (MeCN, formic acid) were purchased from Fisher Scientific and
the employed ultrapure H2O was purified with a Milli-Q Reference
Water Purification System. Electrospray ionization mass spectrometry
was conducted in positive ion mode (m/z range: 50-3200) using a
fragmentor voltage of 150 V, gas temperature of 325 ꢀC (flow 10 L/
min) and sheath gas temperature of 400 ꢀC (flow 11 L/min).
raw data). Each reaction was performed in a 10 mL fritted syringe con-
taining a magnetic stirrer bar. N-acetyl cysteine (113 mg, 4 eq. or
282 mg, 10 eq.), Cs2CO3 (450 mg, 8 eq. or 1129 mg 20 eq.) were
added to the reaction vessel, followed by a solution of HFB (20 μL,
1 eq.) in DMSO (5 mL or 10 mL), leaving no headspace. The reac-
tion vessel was then capped and stirred for 4 or 168 hours at the
appropriate temperature (21 ꢀC or 50 ꢀC). For experiments that
were performed at an elevated temperature of 50 ꢀC the vessel
was stirred in a water bath at 50 ꢀC, maintained by using a tem-
perature probe. At the completion of the reaction, the contents of
the syringe were filtered through the frit and 700 μL was used for
19F NMR analysis (data provided in Figures S5-S35). Statistical
analysis, including ANOVA, factorial regression and main effects
plots were generated in Minitab.
2.4
|
Model reactions - OVAT approach
Reactions were performed in 14 mL screw top vials and stirred using
stirrer bars and magnetic stirrer-plates. N-acetyl L-cysteine (113 mg,
0.692 mmol, 4 eq.), the required solvent (5 mL), the required base
(3.46 mmol, 20 eq.) and HFB (20 μL, 0.173 mmol, 1 eq.) were added
to the reaction vessel and mixtures were stirred for 4 hours at 21 ꢀC.
The reaction outcomes were analyzed with 19F NMR in order to mea-
sure the percentage of unreacted HFB and various substitution prod-
ucts. The above general procedure was applied to combinations of
solvents (THF, MeCN, DMF, DMSO and PC) and bases (DIPEA,
cesium carbonate and DBU) as indicated. 1,4-disubstitution product
(3): HRMS [M + H]+ m/z for [C16H17F4N2O6S2]+ calculated
473.03859, found 473.04691; 1,2,4,5-tetrasubstitution product (4):
HRMS [M + H]+ m/z for [C26H33F2N4O12S4]+ calculated 759.08676,
found 759.09531. See Supporting Information for complete LCMS
characterization (Figure S3).
2.6
|
Solid phase peptide synthesis
Each linear di-cysteine peptide sequence was prepared using auto-
mated Fmoc-SPPS methods on a CEM Liberty Blue microwave-
assisted peptide synthesizer. Solid-phase synthesis was conducted
using Rink amide Pro-Tide resin (180 mg, 0.56 mmol/g loading;
0.1 mmol), employing the required Fmoc amino acids (0.2 M in DMF,
5 eq.); DIC (1 M stock solution in DMF; 10 eq.) as activator, Oxyma
Pure (1 M stock solution, 5 eq.) as racemisation suppressor, and piper-
idine (20% v/v in DMF; 587 eq., 4 mL) as deprotection agent. Standard
coupling procedures employed single coupling of each amino acid
(2.5 minutes, 90 ꢀC) and Fmoc-deprotection (2 minutes, 90 ꢀC). Race-
misation-prone amino acids bearing thermally-sensitive protecting
groups, for example, Fmoc-Cys(Trt)-OH were coupled under milder
conditions (10 minutes, 50 ꢀC). Following on-resin synthesis of the
appropriate sequence, the resin was transferred in 10 mL syringes
with frits and shrank with Et2O. Finally, peptides were cleaved from
the resin as the C-terminal amide by treatment with a cleavage cock-
tail comprising TFA, TIPS and H2O (8:1:1 v/v) with shaking at 21 ꢀC
for 4 hours. Peptides were precipitated from cleavage solutions by
dropwise addition into cold Et2O followed by centrifugation. The
resulting pellet was successively suspended in cold Et2O and cen-
trifuged twice further. The solids obtained after Et2O removal and its
complete evaporation were analyzed by LCMS. For LCMS analysis,
the peptide was dissolved in H2O, MeCN or MeOH with 0.1% formic
2.5
|
Factorial design
A two-level FD space was generated in Minitab (version 19) to assess
the influence of 5 factors: thiol (mol. eq.), base (mol. eq.), reaction time
(h), temperature (ꢀC) and reaction volume (mL) (Table 2). High (maxi-
mum) and low (minimum) values for each factor chosen based on ear-
lier observations, were combined in an array of 32 individual
experiments (See Supporting Information for complete details and